1. Research Report on China's Antidepressant Market, 2013-2017
Report Details:
Published:December 2012
No. of Pages: 50
Price: Single User License – US$2800
Oct. 10 is "World Mental Health Day". In 2012, its theme is "Depression: a Global Crisis".
According to statistics from the United Nations, about 350 million people suffer from depression in
the world. Approximately one million people commit suicide every year because of depression.
Depression becomes a health crisis worldwide.
Depression (also DEP) is a set of mood disorders or affective disorders with the main symptom of
depression caused by various reasons. It is a set of clinical syndrome or conditions centered by
the depression of mood self-experience, which is characterized by chronicity, repeated outbreak
and various symptoms such as depressed mood, sorrow and pain, lack of interest and pleasant
sensation and no motivation. It is generally believed that the morbidity of depression is mainly
associated with biochemical factors such as 5-HT, DA and NE, genetic factors as well as social
and environmental factors.
In developed countries, the sales volume of medicines for depression and anxiety disorder
amounts to 45% of market share of nervous centralis medicines. Depressant medicines and
schizophrenia drugs totally account for 80% of world's mental disorder medicines. There are totally
50 to 60 varieties of antidepressants on the market or in development, which is more than
therapeutic agents of schizophrenia. According to reports, the current eight best-selling
antidepressants globally are Fluoxetine, Paroxetine, Sertraline, Fluvoxamine, Venlafaxine,
Mirtazapine, Duloxetine and Amitriptyline, and the total sales amount exceeds 80% of global
antidepressant market.
With the rapid development of economy, continuous improvement in people's living standards,
continuously-intensified social competition, recombination of labor forces and changes in
population and family structures, depression presents an obviously increasing trend in China. It is
estimated that there are over 30 million depression patients in China, among which more than
90% cannot be promptly diagnosed and treated, causing deterioration of diseases and even
serious consequences of committing suicide. Statistics show that committing suicide becomes an
important cause of death among young adults aged between 15 and 34 in China. Among these
crowds, depression patients account for about two-thirds.

2. At present, the market size of China's antidepressants is very small. In 2012, the market size of
China's antidepressants in hospital medicines is only about CNY 3.2 billion, with an increase of
22.6% YOY. In terms of national medicine market, the antidepressant market is still in a small size
on the whole. However, with the increasing recognition rate of doctors for depression and people's
changes in treatment concepts, it is expected that the future potential of China's antidepressant
market is fairly great. It is predicted that in coming years, the annual growth rate of market size of
China's antidepressants in hospital medicines will maintain over 20%.
More following information can be acquired through this report:
•Morbidity of China's Depression
•Current Market of China's Antidepressants in Hospital Medicines
•Competition in China's Antidepressant Market
•Development Trends of Technologies and Market of China's Antidepressants
Following people are recommended to buy this report:
•Antidepressant Manufacturers
•Pharmaceutical Trade Enterprises and Hospitals
•Investors and Research Institutions Focusing on Pharmaceutical Industry
Get your copy of this report @
http://www.reportsnreports.com/reports/213580-research-report-on-chinas-antidepressant-market-2013-2017.html
Major points covered in Table of Contents of this report include
Table of Contents
1 Overview on Antidepressants
1.1 Current Clinical Application of Antidepressants
1.2 Monoamine Oxidase Inhibitors (MAOI)
1.3 Tricyclic Antidepressants (TCA)
1.4 Selective 5-HT Reuptake Inhibitors (SSRI)
1.4.1 Fluoxetine
1.4.2 Paroxetine
1.4.3 Setraline
1.4.4 Fluvoxamine
1.4.5 Citalopram
1.4.6 Escitalopram
1.5 NARI
1.5.1 Maprotiline
1.5.2 Reboxetine
1.5.3 Mianserine
1.6 SNRI
1.6.1 Venlafaxine
1.6.2 Trazodone
1.6.3 Nefazodone

3. 1.6.4 Mirtazapine
1.6.5 Duloxetine
1.7 Plant Antidepressants
1.8 Others
1.8.1 Tianeptine
1.8.2 Deanxit
1.8.3 Loripram
1.8.4 S-aemesyl-methionine
2 Market Conditions of China's Antidepressants, 2011-2012
2.1 Market Size of Antidepressants in Hospital Medicines
2.2 Market Share of Antidepressants
2.3 Market Share of Major Antidepressant Manufacturers
2.4 Growth Rates of Major Antidepressant Varieties in Market
3 Analysis on Major Varieties of China's Antidepressants, 2011-2012
3.1 Fluoxetine
3.2 Venlafaxine
3.3 Sertraline
3.4 Citalopram
3.5 Mirtazapine
3.6 Fluvoxamine
3.7 Trazodone
3.8 Clomipramine
3.9 Duloxetine
3.10 Neurostan (Extract of St. John's Wort)
4 Reference Prices of China's Major Antidepressants, 2012
5 Prediction on Development of China's Antidepressants, 2013-2017
5.1 Prediction on Market Size
5.2 Technological Trends
List Of Charts
Chart Market Size of Global Antidepressants, 2007-2011
Chart Market Size of China's Antidepressants in Hospital Medicines, 2007-2012
Chart Market Shares of China's Major Antidepressant Varieties in Hospital Medicines, 2008-2011
Chart Market Shares of China's Fluoxetine Enterprises in Hospital Medicines, 2010-2011
Chart Market Size of China's Fluoxetine in Hospital Medicines, 2010-2011
Chart Market Shares of China's Venlafaxine Enterprises in Hospital Medicines, 2010-2011
Chart Market Shares of China's Sertraline Enterprises in Hospital Medicines, 2010-2011

4. Chart Market Shares of China's Citalopram Enterprises in Hospital Medicines, 2010-2011
Chart Market Shares of China's Mirtazapine Enterprises in Hospital Medicines, 2010-2011
Chart Prediction on Market Size of China's Antidepressants in Hospital Medicines, 2013-2017
Contact: sales@reportsandreports.com for more information.